These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8455418)

  • 21. Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons.
    Geertsma MF; van Wengen-Stevenhagen A; van Dam EM; Risberg K; Kroon FP; Groeneveld PH; Nibbering PH
    J Infect Dis; 1999 Sep; 180(3):649-58. PubMed ID: 10438351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
    Van der Bij AK; Coutinho RA; Van der Poel CL
    Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Porphyrin abnormalities in acquired immunodeficiency syndrome.
    O'Connor WJ; Murphy GM; Darby C; Fogarty J; Mulcahy F; O'Moore R; Barnes L
    Arch Dermatol; 1996 Dec; 132(12):1443-7. PubMed ID: 8961872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preliminary investigation on the relation between clinical progress and anti-small monomolecular peptides antibody in individual infected with HIV].
    Xu X; Xing H; Gong W; Chen H; Si C; Wang Y; Chermann JC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):286-7. PubMed ID: 12665943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.
    Benjamin RJ; Busch MP; Fang CT; Notari EP; Puren A; Schoub BD; Tobler LH; Hogrefe W; du P Heyns A; Stramer SL; Crookes RL
    Transfusion; 2008 Feb; 48(2):295-303. PubMed ID: 18005322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human immunodeficiency virus type 1-related transient neurological deficits.
    Brew BJ; Miller J
    Am J Med; 1996 Sep; 101(3):257-61. PubMed ID: 8873486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianópolis--Brazil.
    Treitinger A; Spada C; Ferreira LA; Neto MS; Reis M; Verdi JC; de Miranda AF; de Oliveira OV; Van der Sander Silveira M; Abdalla DS
    Braz J Infect Dis; 2000 Aug; 4(4):192-6. PubMed ID: 11008223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users.
    Tun W; Gange SJ; Vlahov D; Strathdee SA; Celentano DD
    Clin Infect Dis; 2004 Apr; 38(8):1167-74. PubMed ID: 15095224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splenic infarction associated with anticardiolipin antibodies in a patient with acquired immunodeficiency syndrome.
    Cappell MS; Simon T; Tiku M
    Dig Dis Sci; 1993 Jun; 38(6):1152-5. PubMed ID: 8508712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection.
    Cepok S; von Geldern G; Nolting T; Grummel V; Srivastava R; Zhou D; Hartung HP; Adams O; Arendt G; Hemmer B
    Ann Neurol; 2007 Nov; 62(5):458-67. PubMed ID: 17703460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
    Barber Y; Rubio C; Fernández E; Rubio M; Fibla J
    J Infect Dis; 2001 Nov; 184(10):1279-88. PubMed ID: 11679916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users.
    Zehender G; De Maddalena C; Bosisio AB; Gianotto M; Santambrogio S; Moroni M; Galli M
    J Hum Virol; 1998; 1(2):96-100. PubMed ID: 10195238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection.
    Netski DM; Mosbruger T; Astemborski J; Mehta SH; Thomas DL; Cox AL
    J Infect Dis; 2007 Mar; 195(6):857-63. PubMed ID: 17299716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users.
    Schinkel J; Langendam MW; Coutinho RA; Krol A; Brouwer M; Schuitemaker H
    J Infect Dis; 1999 Apr; 179(4):825-31. PubMed ID: 10068577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus type 1 and mucosal humoral defense.
    Janoff EN; Scamurra RW; Sanneman TC; Eidman K; Thurn JR
    J Infect Dis; 1999 May; 179 Suppl 3():S475-9. PubMed ID: 10099123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Follow-up serological study of herpes simplex and cytomegalovirus in Cuban patients infected with human immunodeficiency virus (HIV)].
    Resik S; Santana E; Rivero J; Pérez AB; Kourí V; Larralde O
    Rev Cubana Med Trop; 1997; 49(2):113-9. PubMed ID: 9685973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II.
    Hisada M; Chatterjee N; Zhang M; Battjes RJ; Goedert JJ
    J Infect Dis; 2003 Sep; 188(6):891-7. PubMed ID: 12964121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission.
    Nerurkar VR; Chua PK; Hoffmann PR; Dashwood WM; Shikuma CM; Yanagihara R
    J Med Virol; 1998 Oct; 56(2):123-7. PubMed ID: 9746067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors.
    De La Fuente L; Bravo MJ; Barrio G; Parras F; Suárez M; Rodés A; Noguer I
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S410-5. PubMed ID: 14648456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of a variant of SENV in intravenous drug user HIV-infected patients.
    Pirovano S; Bellinzoni M; Matteelli A; Ballerini C; Albertini A; Imberti L
    J Med Virol; 2002 Sep; 68(1):18-23. PubMed ID: 12210426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.